Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell

31 May 2023

Abstract excerpt

Cancer immunotherapies have improved human health, and one among the important technologies for cancer immunotherapy is cancer vaccine. Antigens are the most important components in cancer vaccines. Generally, antigens in cancer vaccines can be divided into two categories: pre-defined antigens and unidentified antigens. Although, cancer vaccines loaded with predefined antigens are commonly used, cancer vaccine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Cancer Research and Treatments
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37254712
DOI: 10.1002/advs.202300121

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor CellPMID 37254712Read ↗

Cancer Vaccines: Antigen Selection StrategySemantic proximity Read ↗

Strategies for developing and optimizing cancer vaccinesSemantic proximity Read ↗

Advances of mRNA vaccine in tumor: a maze of opportunities and challengesSemantic proximity Read ↗

Engineering neoantigen vaccines to improve cancer personalized immunotherapySemantic proximity Read ↗

[Identification of tumor antigens: strategies and perspectives].Semantic proximity Read ↗

In vivo vaccination with cell line-derived whole tumor lysates – neoantigen quality, not quantity mattersSemantic proximity Read ↗

Cancer Vaccines: Recent Insights and Future DirectionsSemantic proximity Read ↗

Emerging Strategies in TCR-Engineered T CellsSemantic proximity Read ↗

Identification of human tumor antigens and its implications for diagnosis and treatment of cancerSemantic proximity Read ↗

Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigensSemantic proximity Read ↗

Human Tumor Antigens Yesterday, Today, and TomorrowSemantic proximity Read ↗

Focusing on CD8+ T-cell phenotypes: improving solid tumor therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.